| NEWS RSS | TV | RADIO |

| LES NOUVELLES EN MULTIMEDIA | DIE MULTIMEDIA NACHRICHTEN |

News des emetteurs d'actions (en)

Vous voulez observer attentivement le marché? Alors bénéficiez du service offert gratuitement par SIX Swiss Exchange: nous publions quotidiennement les messages de la publicité événementielle des entreprises côtées auprès de nous.
  1. Eastern Property Holdings Limited (EPH):First quarter 2020 Financial Update
  2. Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting
  3. Novartis announces long-term, relapse-free survival benefit for high-risk, stage III melanoma patients treated with Tafinlar® + Mekinist® following surgery
  4. Novartis Piqray® receives positive CHMP opinion to treat HR+/HER2- advanced breast cancer with a PIK3CA mutation
  5. CHMP recommends EU approval of Roche’s Rozlytrek for people with NTRK fusion-positive solid tumours and for people with ROS1-positive, advanced non-small cell lung cancer
  6. Cassiopea announces EUR 23.25 million capital increase by way of rights offering through the issuance of 750,000 shares at an offer price of EUR 31.00 per share
  7. Succès du lancement de l’Helvetia (CH) Swiss Property Fund
  8. Santhera Provides Update on the Ongoing Regulatory Review of Puldysa® (Idebenone) by the CHMP in Duchenne Muscular Dystrophy (DMD)
  9. Cassiopea announces results of extraordinary shareholders meeting
  10. Updated data demonstrate Roche’s Alecensa increases overall survival rate for people with ALK-positive non-small cell lung cancer
  11. ObsEva SA to present at the Jefferies Virtual Healthcare Conference June 3rd, 2020
  12. SGS Appoints Edward Zartler Ph.D as Director of Biopharmaceutical Services in the USA
  13. US CPSC Issues a Direct Final Rule for Sling Carriers
  14. Givaudan completes the acquisition of the cosmetics business of Indena
  15. The International Hockey Federation (FIH) and NAGRA sign a ten-year partnership to deliver a game changing digital experience for fans
  16. Basilea provides corporate update
  17. Roche’s OCREVUS (ocrelizumab) shorter 2-hour infusion time approved in Europe
  18. Implenia et Ina Invest annoncent les termes d'une offre de souscription d'approximativement CHF 100 millions
  19. L'Helvetia Venture Fund investit dans la TrustTech suisse Skribble
  20. Landis+Gyr publishes Annual Report 20 19 and Invitation to AGM 20 20

 

 

logo webdesign swiss.net

infos bourse